Paulus Kirchhof: Oral Anticoagulation in Atrial Fibrillation After Intracranial Hemorrhage
Paulus Kirchhof, Professor of Medicine (Cardiology) and Director of the Department of Cardiology at the University Medical Center Hamburg-Eppendorf, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical Medicine, adding:
“Oral anticoagulation appears safe in selected patients with atrial fibrillation and prior introcranial hemorrhage.
In light of the presented results of the ENRICH-AF study, this finding clearly calls for precision medicine:
Not all patients with prior intracranial hemorrhage are suitable for oral anticoagulation with factor X or II inhibitors (DOACs).”
Title: Intracranial Haemorrhage and Haemorrhagic Stroke in Patients with Atrial Fibrillation on Edoxaban in ETNA-AF-Europe
Authors: Doralisa Morrone, Richa Chhabra, Eva-Maria Fronk, Jose Souza, Paulus Kirchhof , Raffaele De Caterina
Other posts featuring Paulus Kirchhof on Hemostasis Today.
-
Nov 11, 2026, 11:28Arturo Cesaro: Lp(a) Lowered by 78% but Cardiovascular Outcomes Remain Unchanged
-
Nov 11, 2026, 09:40Diego Martin Rabasedas: Celebrating National Voluntary Blood Donor Day in Argentina
-
Nov 11, 2026, 09:32Nathan Connell: Can a Thrombophilic Factor VIII Variant Inform Future Hemophilia A Therapies?
-
Nov 11, 2026, 09:24Amer Zeidan: Highlights from the 2026 New England Hematologic Disease Symposium
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference